On June 12, 2022, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and Mohammad Ghasemi Chaleshtari of Surrey, to address professional misconduct that occurred on December 5, 2021, when Mr. Ghasemi Chaleshtari falsified a patient's clinical record to conceal a medication error in administering an incorrect dose of Diacetyl Morphine to one patient. He then failed to immediately notify the patient of the error and initiate increased monitoring of the patient for symptoms of opioid toxicity.
The Registrant has voluntarily agreed to terms equivalent to a condition on practice, including:
A two-week suspension and public reprimand for their conduct.
Completion of a course in Professional Ethics.
Consultation with a BCCNM Practice Consultant.
The Inquiry Committee is satisfied that the terms will protect the public.